Moolec Science (Moolec Science) Gross-Profit-to-Asset % : 4.24% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Moolec Science Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Moolec Science's annualized Gross Profit for the quarter that ended in Dec. 2023 was $0.93 Mil. Moolec Science's average Total Assets over the quarter that ended in Dec. 2023 was $21.91 Mil. Therefore, Moolec Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 4.24%.

Moolec Science Gross-Profit-to-Asset % Historical Data

The historical data trend for Moolec Science's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science Gross-Profit-to-Asset % Chart

Moolec Science Annual Data

Trend

Jun21

Jun22

Jun23

Gross-Profit-to-Asset %

-0.96

Moolec Science Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial					-	-	16.44	3.78	4.24

Competitive Comparison of Moolec Science's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Moolec Science's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moolec Science's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Moolec Science's Gross-Profit-to-Asset % falls into.

Moolec Science Gross-Profit-to-Asset % Calculation

Moolec Science's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jun. 2023 )	/	( (Total Assets (A: Jun. 2022 )	+	Total Assets (A: Jun. 2023 ))	/ count )
	=	-0.143	/	( (5.692	+	24.051)	/ 2 )
	=	-0.143	/	14.8715
	=	-0.96 %

Moolec Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	0.928	/	( (22.492	+	21.321)	/ 2 )
	=	0.928	/	21.9065
	=	4.24 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Moolec Science Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Moolec Science's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Moolec Science (Moolec Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411

Website

https://www.moolecscience.com

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system.